Selegiline HCl

Selegiline HCl
Trade Name Eldepryl
Orphan Indication As an adjuvant to levodopa and carbidopa treatment of idiopathic Parkinson's disease (paralysis agitans), postencephalitic Parkinsonism, and symptomatic Parkinsonism
USA Market Approval USA
USA Designation Date 1984-11-07 00:00:00
Sponsor Somerset Pharmaceuticals, Inc.;400 Morris Ave., Suite 7s;Denville, New Jersey, 07834